oral tirzepatide development status Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study | Diabetologia Lilly orforglipron oral GLP-1 phase

The new approval for Retevmo, which was previously authorized to treat patients 12 and older with RET-positive thyroid cancers, is based on a single-arm study that showed an overall response rate of 48%, with a median duration of response not reached after 12 months of follow-up

doi: 10.1172/JCI12673 37 HaflerDA

Any weight you manage to keep off continues to work in your favor keeping your blood pressure lower, your blood sugar more stable, and your cholesterol in a better place

In this case, cancer will likelyhave spreadto lymph nodes

A: Contraindications include pregnancy, planning to become pregnant, and breastfeeding

A balanced diet rich in whole foods, along with regular physical activity, will maximize your weight loss and overall health benefits